A proportion of CD4+ T cells from patients with chronic Chagas disease undergo a dysfunctional process, which is partially reversed by benznidazole treatment.
<h4>Background</h4>Signs of senescence and the late stages of differentiation associated with the more severe forms of Chagas disease have been described in the Trypanosoma cruzi antigen-specific CD4+ T-cell population. However, the mechanisms involved in these functions are not fully kn...
Main Authors: | Elena Pérez-Antón, Adriana Egui, M Carmen Thomas, Bartolomé Carrilero, Marina Simón, Miguel Ángel López-Ruz, Manuel Segovia, Manuel Carlos López |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-02-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://doi.org/10.1371/journal.pntd.0009059 |
Similar Items
-
Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole
by: Cristina Vázquez, et al.
Published: (2023-01-01) -
Short-term follow-up of chagasic patients after benznidazole treatment using multiple serological markers
by: Fernández-Villegas Ana, et al.
Published: (2011-07-01) -
Access to benznidazole for Chagas disease in the United States-Cautious optimism?
by: Jonathan D Alpern, et al.
Published: (2017-09-01) -
Differential phenotypic and functional profiles of TcCA-2 -specific cytotoxic CD8+ T cells in the asymptomatic versus cardiac phase in Chagasic patients.
by: Adriana Egui, et al.
Published: (2015-01-01) -
Adverse drug reactions to benznidazole in Chagas disease: management and successful desensitization
by: M, et al.
Published: (2020-08-01)